(UroToday.com) The third Renal Cancer session at this year’s European Association of Urology (EAU) Section of Oncological Urology (ESOU) 2021 virtual meeting focused on the management of patients with advanced and metastatic disease. In this session, Dr. Ravaud addressed the question, “Does every metastatic patient need immunotherapy in a first-line setting?”